Restarting Wegovy After a Month Away: What Actually Changes

Semaglutide has a half-life of roughly one week, so after four weeks off, circulating levels will be very low or undetectable.
Restarting after a break typically means stepping back to a lower dose, not continuing from where you stopped — your tolerance resets.
Appetite and weight can shift noticeably during a month off, which is useful clinical information your prescriber will want to know.
A prescriber reviews your situation before any restart, the dose, timing and any new health changes all factor into that decision.

If you stopped Wegovy and it has been around a month, restarting is possible — but a straightforward pick-up-where-you-left-off is rarely the right move. A four-week gap means your body has been clearing semaglutide from your system, and the way you restart matters both for safety and for how well you tolerate the medicine. These are prescription-only medicines, and any decision about restarting, including which dose to return to, is made with a prescriber who can review your full picture.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How a one-month break changes your restart, and what your prescriber looks at

The myth: after one month, you can just carry on at your previous dose

This is probably the most common assumption people bring to this conversation, and it is understandable. If you had been tolerating 0.5mg or 1mg well before the break, it feels logical to continue there. The reality is different, and it is grounded in how semaglutide behaves in the body.

Wegovy's half-life is approximately one week. That means after four weeks without an injection, the medicine has largely cleared your system. The gastrointestinal adaptation you built up (the gradual adjustment that made those doses manageable) fades with it. Jumping straight back to the dose you stopped at raises the risk of side effects that the titration schedule was specifically designed to avoid: pronounced nausea, vomiting, and the kind of stomach discomfort that makes people want to stop again.

The NHS medicines page for semaglutide describes the standard weekly injection schedule and notes that doses are increased gradually by a prescriber. That graduated approach exists for a reason, and after a significant break, the starting point shifts accordingly. Your prescriber will generally recommend stepping back (often to 0.25mg or the next step up) before building again. Worth knowing before you restart rather than after.

What a month off actually does to your weight and appetite

One thing people are often surprised by is how quickly appetite returns once semaglutide clears the system. For many people, hunger signals that had been quiet during treatment come back within days of stopping. Over four weeks, this can translate to meaningful weight regain, sometimes several kilograms, sometimes less, depending on how long someone had been on treatment and how well lifestyle habits held up in the meantime.

This is not a reason to feel discouraged. It is, however, clinically relevant. Your prescriber needs an accurate picture of where things stand now: your current weight, any symptoms that emerged during the break, and whether anything in your health has changed. If you are thinking about what the ongoing cost of treatment looks like, our guide to Wegovy costs in the UK covers what private treatment typically includes and what the price reflects.

The broader semaglutide evidence base, including the STEP 1 trial published in the New England Journal of Medicine, showed that weight tends to return when treatment stops, which is part of why clinical guidelines treat weight management as an ongoing process rather than a fixed course.

The restart conversation: what your prescriber considers

A one-month gap puts you in a specific position. You have prior experience of the medicine, which is useful. You probably know how your body responded to the early doses, what side effects you noticed and when they eased. That history matters, and a good prescriber will draw on it.

They will also look at what has happened in the past month: any new medications (some interact with semaglutide's absorption or effect), any health changes, and your current weight and BMI. The Wegovy treatment overview covers eligibility criteria in more detail, including the BMI thresholds under the UK licence.

If you were prescribed Wegovy through another service and want to restart through a different route, a prescriber will typically ask for evidence of your previous treatment, the dose you were on and how long you had been there. That is standard practice and protects you. Semaglutide is a prescription-only medicine regulated by the MHRA, and any service offering it without a proper clinical assessment is one to avoid.

Some people find that even a short break gives them a chance to reflect on what was working well alongside the medicine. Physical activity, protein intake and hydration all affect how the treatment period goes. Our weight-loss overview covers the lifestyle context that tends to sit alongside medical treatment.

A practical check before you restart

Before booking anything, take a minute to do one simple thing: look up the pharmacy you plan to use on the GPhC pharmacy register. Any legitimate online pharmacy dispensing prescription-only medicines in the UK should be listed there. It takes less than sixty seconds and confirms you are dealing with a regulated service, not one of the unverified sellers the MHRA has repeatedly warned about in connection with fake weight-loss pens.

Once you have confirmed that, the next step is a consultation. At nume, a GPhC-registered prescriber reads every consultation personally before any prescription is issued. If you are restarting after a month off, they will ask about your current health, review the appropriate dose for your situation, and confirm whether Wegovy remains the right fit, or whether a broader look at semaglutide options makes more sense for where you are now.

If your break has stretched longer than a month, the considerations shift a little further. Our page on restarting Wegovy after two months covers what changes at that point, and the three-month page goes further still. If you want a detailed guide to restarting semaglutide after a month specifically, that page walks through the clinical considerations for this exact gap. Speak to our prescribers to get a clear answer for your specific situation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions